Corrigendum to 'Urinary incontinence and erectile dysfunction in patients with localized or locally advanced prostate cancer: A nationwide observational study' (Urologic Oncology: Seminars and Original Investigations (2020) 38(9) (735.e17–735.e25), (S1078143920302519), (10.1016/j.urolonc.2020.05.022))

Autor: Vernooij, R. W. M., Cremers, R. G. H. M., Jansen, H., Somford, D. M., Kiemeney, L. A., van Andel, G., Wijsman, B. P., Busstra, M. B., van Moorselaar, R. J. A., Wijnen, E. M., Pos, F. J., Hulshof, M. C. C. M., Hamberg, P., van den Berkmortel, F., Hulsbergen-van de Kaa, C. A., van Leenders, G. J. L. H., F€utterer, J. J., van Oort, I. M., Aben, K. K. H.

Publikováno v: Urologic Oncology: Seminars and Original Investigations, 40(7). Elsevier Inc.
Vernooij, R W M, Cremers, R G H M, Jansen, H, Somford, D M, Kiemeney, L A, van Andel, G, Wijsman, B P, Busstra, M B, van Moorselaar, R J A, Wijnen, E M, Pos, F J, Hulshof, M C C M, Hamberg, P, van den Berkmortel, F, Hulsbergen-van de Kaa, C A, van Leenders, G J L H, F€utterer, J J, van Oort, I M & Aben, K K H 2022, ' Corrigendum to “Urinary incontinence and erectile dysfunction in patients with localized or locally advanced prostate cancer : A nationwide observational study” (Urologic Oncology: Seminars and Original Investigations (2020) 38(9) (735.e17–735.e25), (S1078143920302519), (10.1016/j.urolonc.2020.05.022)) ', Urologic Oncology: Seminars and Original Investigations, vol. 40, no. 7, pp. 353 . https://doi.org/10.1016/j.urolonc.2022.05.007
Urologic oncology, 40(7). Elsevier Inc.

The authors regret that the following statements were incorrectly mentioned in the paper. Page 4, line 333, paragraph 3.1. Descriptive statistics: “.2358.” should be 2538 Page 4, line 338-340, paragraph 3.1. Descriptive statistics: “.and were t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::5db9ac6c33daac385d9187bc05ef619d
https://research.vumc.nl/en/publications/7bf2f294-6884-4306-b65e-14f0de58c5d3

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A phase II study of temozolomide in hormone-refractory prostate cancer.

Autor: van Brussel, Jérôme P., Busstra, Martijn B., Lang, Margreet S., Catsburg, Tilly, Schröder, Fritz H., Mickisch, Gerald H., van Brussel, J P, Busstra, M B, Lang, M S, Catsburg, T, Schröder, F H, Mickisch, G H

Publikováno v: Cancer Chemotherapy & Pharmacology; Jun2000, Vol. 45 Issue 6, p509-512, 4p

A prospective multicenter comparison study of a risk-adapted ultrasound-directed and MRI-directed diagnostic pathway in prostate cancer suspected biopsy naive men

Autor: Wagensveld, I. M., Osses, D. F., Groenendijk, P. M., Zijta, F. M., Busstra, M. B., Rociu, E., Barentsz, J. O., Michiel Sedelaar, Arbeel, B., Roeleveld, T., Geenen, R., Koeter, I., Meer, S. A., Cappendijk, V., Somford, R., Klaver, S., Lely, H., Wolters, T., Hellings, W., Leter, M. R., Poel, H. G., Heijmink, S. W. T. P. J., Debruyne, F., Immerzeel, J., Schoots, I. G.

Publikováno v: Web of Science

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02ebbb7bf85473df9ddd2f3c95d486cd
https://publons.com/wos-op/publon/53712403/